Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

India’s Domestic Drugs Market Slowed to 9.8% Growth, PwC Says

Dec. 20 (Bloomberg) -- Growth in India’s domestic pharmaceuticals market slowed to 9.8 percent this year from 16.6 percent in 2012, PwC India said.

A 2013 government drug price control order slowed revenue growth of pharmaceutical companies and free medicine programs introduced in some states also dented growth in the domestic market, Sujay Shetty, the firm’s leader of pharmaceuticals and life sciences, and Krishnakumar Sankaranarayanan, an associate director, said in a e-mailed statement yesterday.

“Looking ahead to 2014, Indian companies will look to redesign their product portfolio keeping in mind the price control requirements,” they said. “They will look to take advantage of the opportunities offered by biosimilars. To be able to capitalize on these opportunities, Indian pharmaceutical companies would need to renew their focus on manufacturing quality to ensure that they are adherent to the norms of the regulatory agencies.”

Link to Company News:{RBXY IN <Equity> CN <GO>} Link to Company News:{DRRD IN <Equity> CN <GO>} Link to Company News:{SUNP IN <Equity> CN <GO>} Link to Company News:{CIPLA IN <Equity> CN <GO>} Link to Company News:{WPL IN <Equity> CN <GO>} Link to Company News:{BOOT IN <Equity> CN <GO>} Link to Company News:{GLXO IN <Equity> CN <GO>} Link to Company News:{10182Z US <Equity> CN <GO>}

To contact the reporter on this story: Jason Gale in Melbourne at j.gale@bloomberg.net

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.